197 related articles for article (PubMed ID: 31707669)
1. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells.
Do Minh A; Tran MY; Kamen AA
Methods Mol Biol; 2020; 2086():77-83. PubMed ID: 31707669
[TBL] [Abstract][Full Text] [Related]
2. Optimized Production of Lentiviral Vectors for CAR-T Cell.
Moço PD; de Abreu Neto MS; Fantacini DMC; Picanço-Castro V
Methods Mol Biol; 2020; 2086():69-76. PubMed ID: 31707668
[TBL] [Abstract][Full Text] [Related]
3. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells.
Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K
Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene.
Yuan W; Chen J; Cao Y; Yang L; Shen L; Bian Q; Bin S; Li P; Cao J; Fang H; Gu H; Li H
J Gene Med; 2018 Jul; 20(7-8):e3027. PubMed ID: 29851200
[TBL] [Abstract][Full Text] [Related]
5. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
[TBL] [Abstract][Full Text] [Related]
6. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
[TBL] [Abstract][Full Text] [Related]
7. Production of Lentivirus for the Establishment of CAR-T Cells.
Lana MG; Strauss BE
Methods Mol Biol; 2020; 2086():61-67. PubMed ID: 31707667
[TBL] [Abstract][Full Text] [Related]
8. Generation of CAR-T Cells for Cancer Immunotherapy.
Xu Q; Harto H; Berahovich R; Xu S; Zhou H; Golubovskaya V; Wu L
Methods Mol Biol; 2019; 1884():349-360. PubMed ID: 30465215
[TBL] [Abstract][Full Text] [Related]
9. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
10. Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors.
Mo F; Mamonkin M
Methods Mol Biol; 2020; 2086():119-130. PubMed ID: 31707671
[TBL] [Abstract][Full Text] [Related]
11. Antibody-Based CAR T Cells Produced by Lentiviral Transduction.
Prommersberger S; Hudecek M; Nerreter T
Curr Protoc Immunol; 2020 Mar; 128(1):e93. PubMed ID: 32150338
[TBL] [Abstract][Full Text] [Related]
12. Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes.
Hammill JA; Afsahi A; Bramson JL; Helsen CW
Methods Mol Biol; 2016; 1458():137-57. PubMed ID: 27581020
[TBL] [Abstract][Full Text] [Related]
13. Progress and Perspectives in the Development of Lentiviral Vector Producer Cells.
Ferreira MV; Cabral ET; Coroadinha AS
Biotechnol J; 2021 Jan; 16(1):e2000017. PubMed ID: 32686901
[TBL] [Abstract][Full Text] [Related]
14. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
[TBL] [Abstract][Full Text] [Related]
15. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy.
Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC
Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682
[TBL] [Abstract][Full Text] [Related]
16. Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope.
Mirow M; Schwarze LI; Fehse B; Riecken K
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452336
[TBL] [Abstract][Full Text] [Related]
17. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
18. Production of human CAR-NK cells with lentiviral vectors and functional assessment
Portillo AL; Hogg R; Ashkar AA
STAR Protoc; 2021 Dec; 2(4):100956. PubMed ID: 34825217
[TBL] [Abstract][Full Text] [Related]
19. Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects.
Poorebrahim M; Sadeghi S; Fakhr E; Abazari MF; Poortahmasebi V; Kheirollahi A; Askari H; Rajabzadeh A; Rastegarpanah M; Linē A; Cid-Arregui A
Crit Rev Clin Lab Sci; 2019 Sep; 56(6):393-419. PubMed ID: 31314617
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Differentiation of T Cell: From CAR-Modified T-iPSC.
Ueda T; Kaneko S
Methods Mol Biol; 2019; 2048():85-91. PubMed ID: 31396933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
